Literature DB >> 8385535

Effects of propafenone on calcium current in guinea-pig ventricular myocytes.

C Delgado1, J Tamargo, D Henzel, P Lorente.   

Abstract

1. The modulation of L-type voltage-sensitive calcium channels in guinea-pig isolated ventricular myocytes by propafenone was examined by the whole cell voltage-clamp technique. 2. Propafenone, 10(-7) -5 x 10(-5) M, produced a concentration-dependent inhibition of Ca current (ICa) without any significant change in the current-voltage relation. Half-blocking concentration (IC50) of propafenone for the peak ICa at +10 mV was 5 x 10(-6) M. 3. The voltage-dependence of ICa inactivation was shifted in the hyperpolarizing direction in the presence of 5 x 10(-6) M propafenone. 4. A frequency-dependent relative block by propafenone was observed after repetitive depolarizing test pulses at a frequency of 0.5 and 1 Hz. The recovery of ICa from inactivation was prolonged by propafenone and the reactivation exhibited an additional exponential component attributed to the slow release from drug block of Ca channels. 5. These results suggest that propafenone, at therapeutic concentrations exhibits Ca channel blocking properties that may be involved in its antiarrhythmic mechanism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8385535      PMCID: PMC1908021          DOI: 10.1111/j.1476-5381.1993.tb12868.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  39 in total

1.  A quantitative description of membrane current and its application to conduction and excitation in nerve.

Authors:  A L HODGKIN; A F HUXLEY
Journal:  J Physiol       Date:  1952-08       Impact factor: 5.182

Review 2.  Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels.

Authors:  L M Hondeghem; B G Katzung
Journal:  Biochim Biophys Acta       Date:  1977-11-14

3.  Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction.

Authors:  B Hille
Journal:  J Gen Physiol       Date:  1977-04       Impact factor: 4.086

4.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

5.  AQA 39*, a new bradycardic agent which blocks myocardial calcium (Ca) channels in a frequency- and voltage-dependent manner.

Authors:  W Trautwein; D Pelzer; T F McDonald; W Osterrieder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-11       Impact factor: 3.000

6.  Correlation between serum concentration and pharmacological effect on atrioventricular conduction time of the antiarrhythmic drug propafenone.

Authors:  K Keller; G Meyer-Estorf; O A Beck; H Hochrein
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953

7.  The voltage- and time-dependent effects of (-)-verapamil on the slow inward current in isolated cat ventricular myocardium.

Authors:  T Ehara; R Daufmann
Journal:  J Pharmacol Exp Ther       Date:  1978-10       Impact factor: 4.030

8.  On the mechanism of slow calcium channel block in heart.

Authors:  T F McDonald; D Pelzer; W Trautwein
Journal:  Pflugers Arch       Date:  1980-05       Impact factor: 3.657

9.  Electrophysiological effects of propafenone in untreated and propafenone-pretreated guinea-pig atrial and ventricular muscle fibres.

Authors:  C Delgado; J Tamargo; T Tejerina
Journal:  Br J Pharmacol       Date:  1985-12       Impact factor: 8.739

10.  The pH-dependent rate of action of local anesthetics on the node of Ranvier.

Authors:  B Hille
Journal:  J Gen Physiol       Date:  1977-04       Impact factor: 4.086

View more
  5 in total

1.  Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs.

Authors:  M J McPate; R S Duncan; J C Hancox; H J Witchel
Journal:  Br J Pharmacol       Date:  2008-08-25       Impact factor: 8.739

2.  Cardiovascular pharmacology of K2P17.1 (TASK-4, TALK-2) two-pore-domain K+ channels.

Authors:  Ingo Staudacher; Claudius Illg; Sam Chai; Isabelle Deschenes; Sebastian Seehausen; Dominik Gramlich; Mara Elena Müller; Teresa Wieder; Ann-Kathrin Rahm; Christina Mayer; Patrick A Schweizer; Hugo A Katus; Dierk Thomas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-07-14       Impact factor: 3.000

3.  Voltage- and time-dependent inhibitory effects on rat aortic and porcine coronary artery contraction induced by propafenone and quinidine.

Authors:  F Pérez-Vizcaíno; B Fernández del Pozo; F Zaragozá; J Tamargo
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

4.  Computational Modeling for Antiarrhythmic Drugs for Atrial Fibrillation According to Genotype.

Authors:  Inseok Hwang; Je-Wook Park; Oh-Seok Kwon; Byounghyun Lim; Myunghee Hong; Min Kim; Hee-Tae Yu; Tae-Hoon Kim; Jae-Sun Uhm; Boyoung Joung; Moon-Hyoung Lee; Hui-Nam Pak
Journal:  Front Physiol       Date:  2021-05-13       Impact factor: 4.566

5.  Inhibition of voltage-dependent K+ current in rabbit coronary arterial smooth muscle cells by the class Ic antiarrhythmic drug propafenone.

Authors:  Jin Ryeol An; Hongliang Li; Mi Seon Seo; Won Sun Park
Journal:  Korean J Physiol Pharmacol       Date:  2018-08-27       Impact factor: 2.016

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.